.png)
DLC Board Member George Huntley was quoted in two recent news stories regarding the increasingly high cost of insulin for patients with diabetes. In stories published online by INDYStar on September 8, 2017 and USA Today on September 13, 2017, the DLC and other diabetes advocacy organizations call on Lilly Diabetes and other manufacturers of insulin to be transparent about how much it costs to make insulin and how much they earn from sales of the drug, and further to be proactive in efforts to make the life-saving drug more affordable for patients. Read the INDYStar article here. Read the USA Today article here.
